31641056|t|ApoE4 Alters ABCA1 Membrane Trafficking in Astrocytes.
31641056|a|The APOE epsilon4 allele is the strongest genetic risk factor for late-onset Alzheimer's disease (AD). ApoE protein aggregation plays a central role in AD pathology, including the accumulation of beta-amyloid (Abeta). Lipid-poor ApoE4 protein is prone to aggregate and lipidating ApoE4 protects it from aggregation. The mechanisms regulating ApoE4 aggregation in vivo are surprisingly not known. ApoE lipidation is controlled by the activity of the ATP binding cassette A1 (ABCA1). ABCA1 recycling and degradation is regulated by ADP-ribosylation factor 6 (ARF6). We found that ApoE4 promoted greater expression of ARF6 compared with ApoE3, trapping ABCA1 in late-endosomes and impairing its recycling to the cell membrane. This was associated with lower ABCA1-mediated cholesterol efflux activity, a greater percentage of lipid-free ApoE particles, and lower Abeta degradation capacity. Human CSF from APOE epsilon4/epsilon4 carriers showed a lower ability to induce ABCA1-mediated cholesterol efflux activity and greater percentage of aggregated ApoE protein compared with CSF from APOE epsilon3/epsilon3 carriers. Enhancing ABCA1 activity rescued impaired Abeta degradation in ApoE4-treated cells and reduced both ApoE and ABCA1 aggregation in the hippocampus of male ApoE4-targeted replacement mice. Together, our data demonstrate that aggregated and lipid-poor ApoE4 increases ABCA1 aggregation and decreases ABCA1 cell membrane recycling. Enhancing ABCA1 activity to reduce ApoE and ABCA1 aggregation is a potential therapeutic strategy for the prevention of ApoE4 aggregation-driven pathology.SIGNIFICANCE STATEMENT ApoE protein plays a key role in the formation of amyloid plaques, a hallmark of Alzheimer's disease (AD). ApoE4 is more aggregated and hypolipidated compared with ApoE3, but whether enhancing ApoE lipidation in vivo can reverse ApoE aggregation is not known. ApoE lipidation is controlled by the activity of the ATP binding cassette A1 (ABCA1). In this study, we demonstrated that the greater propensity of lipid-poor ApoE4 to aggregate decreased ABCA1 membrane recycling and its ability to lipidate ApoE. Importantly, enhancing ABCA1 activity to lipidate ApoE reduced ApoE and ABCA1 aggregation. This work provides critical insights into the interactions among ABCA1, ApoE lipidation and aggregation, and underscores the promise of stabilizing ABCA1 activity to prevent ApoE-driven aggregation pathology.
31641056	0	5	ApoE4	Gene	348
31641056	13	18	ABCA1	Gene	19
31641056	59	63	APOE	Gene	348
31641056	132	151	Alzheimer's disease	Disease	MESH:D000544
31641056	153	155	AD	Disease	MESH:D000544
31641056	158	162	ApoE	Gene	348
31641056	207	209	AD	Disease	MESH:D000544
31641056	265	270	Abeta	Gene	351
31641056	273	278	Lipid	Chemical	MESH:D008055
31641056	284	289	ApoE4	Gene	348
31641056	335	340	ApoE4	Gene	348
31641056	397	402	ApoE4	Gene	348
31641056	451	455	ApoE	Gene	348
31641056	504	527	ATP binding cassette A1	Gene	19
31641056	529	534	ABCA1	Gene	19
31641056	537	542	ABCA1	Gene	19
31641056	585	610	ADP-ribosylation factor 6	Gene	382
31641056	612	616	ARF6	Gene	382
31641056	633	638	ApoE4	Gene	348
31641056	670	674	ARF6	Gene	382
31641056	689	694	ApoE3	Gene	348
31641056	705	710	ABCA1	Gene	19
31641056	810	815	ABCA1	Gene	19
31641056	825	836	cholesterol	Chemical	MESH:D002784
31641056	878	883	lipid	Chemical	MESH:D008055
31641056	889	893	ApoE	Gene	348
31641056	915	920	Abeta	Gene	351
31641056	943	948	Human	Species	9606
31641056	958	962	APOE	Gene	348
31641056	1023	1028	ABCA1	Gene	19
31641056	1038	1049	cholesterol	Chemical	MESH:D002784
31641056	1103	1107	ApoE	Gene	348
31641056	1139	1143	APOE	Gene	348
31641056	1182	1187	ABCA1	Gene	11303
31641056	1214	1219	Abeta	Gene	11820
31641056	1235	1240	ApoE4	Gene	348
31641056	1272	1276	ApoE	Gene	348
31641056	1281	1286	ABCA1	Gene	11303
31641056	1326	1331	ApoE4	Gene	348
31641056	1353	1357	mice	Species	10090
31641056	1410	1415	lipid	Chemical	MESH:D008055
31641056	1421	1426	ApoE4	Gene	348
31641056	1437	1442	ABCA1	Gene	19
31641056	1469	1474	ABCA1	Gene	19
31641056	1510	1515	ABCA1	Gene	19
31641056	1535	1539	ApoE	Gene	348
31641056	1544	1549	ABCA1	Gene	19
31641056	1620	1625	ApoE4	Gene	348
31641056	1678	1682	ApoE	Gene	348
31641056	1728	1743	amyloid plaques	Disease	MESH:D058225
31641056	1759	1778	Alzheimer's disease	Disease	MESH:D000544
31641056	1780	1782	AD	Disease	MESH:D000544
31641056	1785	1790	ApoE4	Gene	348
31641056	1842	1847	ApoE3	Gene	348
31641056	1871	1875	ApoE	Gene	348
31641056	1907	1911	ApoE	Gene	348
31641056	1938	1942	ApoE	Gene	348
31641056	1991	2014	ATP binding cassette A1	Gene	19
31641056	2016	2021	ABCA1	Gene	19
31641056	2086	2091	lipid	Chemical	MESH:D008055
31641056	2097	2102	ApoE4	Gene	348
31641056	2126	2131	ABCA1	Gene	19
31641056	2179	2184	ApoE.	Gene	348
31641056	2208	2213	ABCA1	Gene	19
31641056	2235	2239	ApoE	Gene	348
31641056	2248	2252	ApoE	Gene	348
31641056	2257	2262	ABCA1	Gene	19
31641056	2341	2346	ABCA1	Gene	19
31641056	2348	2352	ApoE	Gene	348
31641056	2424	2429	ABCA1	Gene	19
31641056	2450	2454	ApoE	Gene	348
31641056	Association	MESH:D002784	19
31641056	Positive_Correlation	11303	11820
31641056	Association	19	348
31641056	Association	MESH:D008055	19
31641056	Association	19	382
31641056	Association	MESH:D008055	348
31641056	Association	11820	348
31641056	Positive_Correlation	MESH:D008055	11303
31641056	Association	348	382
31641056	Association	11303	348
31641056	Association	MESH:D002784	348
31641056	Association	MESH:D000544	348
31641056	Association	MESH:D058225	348
31641056	Positive_Correlation	11303	19
31641056	Association	348	351

